Does RISANKIZUMAB-RZAA Cause Immunodeficiency? 217 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 217 reports of Immunodeficiency have been filed in association with RISANKIZUMAB-RZAA. This represents 0.3% of all adverse event reports for RISANKIZUMAB-RZAA.
217
Reports of Immunodeficiency with RISANKIZUMAB-RZAA
0.3%
of all RISANKIZUMAB-RZAA reports
5
Deaths
83
Hospitalizations
How Dangerous Is Immunodeficiency From RISANKIZUMAB-RZAA?
Of the 217 reports, 5 (2.3%) resulted in death, 83 (38.2%) required hospitalization, and 4 (1.8%) were considered life-threatening.
Is Immunodeficiency Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RISANKIZUMAB-RZAA. However, 217 reports have been filed with the FAERS database.
What Other Side Effects Does RISANKIZUMAB-RZAA Cause?
Psoriasis (6,896)
Drug ineffective (2,885)
Pain (2,584)
Fatigue (2,483)
Arthralgia (2,419)
Pruritus (2,311)
Covid-19 (2,145)
Death (1,700)
Fall (1,666)
Surgery (1,662)
What Other Drugs Cause Immunodeficiency?
ADALIMUMAB (2,981)
RITUXIMAB (1,256)
TOCILIZUMAB (1,061)
ABATACEPT (1,042)
METHOTREXATE (926)
ETANERCEPT (799)
INFLIXIMAB (693)
CETIRIZINE (650)
METHYLPREDNISOLONE (615)
ALBUTEROL (599)
Which RISANKIZUMAB-RZAA Alternatives Have Lower Immunodeficiency Risk?
RISANKIZUMAB-RZAA vs RISDIPLAM
RISANKIZUMAB-RZAA vs RISEDRONATE
RISANKIZUMAB-RZAA vs RISEDRONIC ACID
RISANKIZUMAB-RZAA vs RISPERDAL
RISANKIZUMAB-RZAA vs RISPERDAL CONSTA